Concepedia

Author

Sylvain Choquet

Sorbonne UniversitéORCID

Also Known As

Caroline Houillier, Choquet Sylvain, Choquet, S, Choquet, S., Choquet, Sylvain, Corinne Haioun, Eirini Katodritou, F Boué, J.-M. Leger, Jean-Marc Leger

504

Publications

12.2K

Citations

57

H-Index

84

Concepts

All Affiliations

Sorbonne UniversitéPitié-Salpêtrière HospitalAssistance Publique – Hôpitaux de ParisInsermInstitut Curie
SC

About

Sylvain Choquet is an author at Sorbonne Université specializing in medicine, oncology, and pathology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

29

47

3.2K

2

Health Sciences

9

9

279

3

Natural Sciences

1

1

18

4

Social Sciences

1

1

45

5

Biochemistry

1

1

18

Sylvain Choquet

×

126

Publications

10.1K

Citations

53

H-Index

YearCitations

Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial

Steven M. Horwitz, Owen A. O’Connor, Barbara Pro,

The Lancet

2018

707

Oral Selinexor–Dexamethasone for Triple-Class Refractory Multiple Myeloma

Ajai Chari, Dan T. Vogl, Maria Gavriatopoulou,

New England Journal of Medicine

2019

655

Efficacy and safety of rituximab in B-cell post-transplantation lymphoproliferative disorders: results of a prospective multicenter phase 2 study

Sylvain Choquet

Blood

2005

421

Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial

Ralf Ulrich Trappe, Stephan Oertel, Véronique Leblond,

The Lancet Oncology

2011

379

A real-world comparison of tisagenlecleucel and axicabtagene ciloleucel CAR T cells in relapsed or refractory diffuse large B cell lymphoma

Emmanuel Bachy, Steven Le Gouill, Roberta Di Blasi,

Nature Medicine

2022

343

Intensive Chemotherapy Followed by Hematopoietic Stem-Cell Rescue for Refractory and Recurrent Primary CNS and Intraocular Lymphoma: Société Française de Greffe de Moëlle Osseuse-Thérapie Cellulaire

Carole Soussain, Khê Hoang‐Xuan, Luc Taillandier,

Journal of Clinical Oncology

2008

325

Selinexor in patients with relapsed or refractory diffuse large B-cell lymphoma (SADAL): a single-arm, multinational, multicentre, open-label, phase 2 trial

Nagesh Kalakonda, Marie Maerevoet, Federica Cavallo,

The Lancet Haematology

2020

324

Ibrutinib monotherapy for relapse or refractory primary CNS lymphoma and primary vitreoretinal lymphoma: Final analysis of the phase II ‘proof-of-concept’ iLOC study by the Lymphoma study association (LYSA) and the French oculo-cerebral lymphoma (LOC) network

Carole Soussain, Sylvain Choquet, Marie Blonski,

European Journal of Cancer

2019

305

Radiotherapy or Autologous Stem-Cell Transplantation for Primary CNS Lymphoma in Patients 60 Years of Age and Younger: Results of the Intergroup ANOCEF-GOELAMS Randomized Phase II PRECIS Study

Caroline Houillier, Luc Taillandier, Sylvain Dureau,

Journal of Clinical Oncology

2019

265

Recurrent Mutations of <i>MYD88</i> and <i>TBL1XR1</i> in Primary Central Nervous System Lymphomas

Alberto González-Aguilar, Ahmed Idbaïh, Blandine Boisselier,

Clinical Cancer Research

2012

236

Page 1